Advertisement

Uterus myomatosus

  • Ricardo E. Felberbaum
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Das Leiomyom ist der häufigste Tumor des weiblichen Geschlechtsorgans. Bei 25–50 % der Myomträgerinnen treten Symptome wie pathologische Blutungen, eine blutungsbedingte Anämie, habituelle Aborte oder eine Sterilität auf. Medikamentöse Therapien basieren auf einer ovariellen Funktionssuppression durch GnRH-Analoga oder dem Einsatz selektiver Progesteron-Rezeptor-Modulatoren. Im Falle pathologischer Blutungen in der Perimenopause ist die Hysterektomie die adäquate Therapie. Neben der vaginalen Hysterektomie stehen die totale laparoskopische Hysterektomie, die laparoskopisch assistierte suprazervikale Hysterektomie oder die Hysterektomie per laparotomiam zu Verfügung. Konservative Verfahren sind die Myomenukleation per laparoskopiam oder laparotomiam, die hysteroskopische Myomabtragung, die Embolisation der A. uterina oder deren Koagulation, die Applikation von hochenergetischem Ultraschall oder die transzervikale ultraschallgesteuerte Hochfrequenzablation.

Literatur

  1. Abbott JA, Garry R (2002) The surgical management of menorrhagia. Hum Reprod Update 8:68–78CrossRefPubMedGoogle Scholar
  2. Arena S, Zupi E (2011) Heavy menstrual bleeding: considering the most effective treatment option. Women’s Health 7:143–146PubMedGoogle Scholar
  3. Arici A, Sozen I (2000) Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73:1006–1011CrossRefPubMedGoogle Scholar
  4. Bends R, Brössner A et al (2016) Myoma in statu nascendi nach transcervikaler Hochfrequenzablation eines transmuralen Leiomyoms des Uterus. Gynecol Endocrinol 14:291–294Google Scholar
  5. Bernard G, Darai E, Poncelet C et al (2000) Fertility after hysteroscopic myomectomy: effect of intramural myomas associated. Eur J Obstet Gynecol Reprod Biol 88:85–90CrossRefPubMedGoogle Scholar
  6. Bongers M, Brölmann H et al (2015) Transcervical, intrauterine ultrasound guided radiofrequency ablation of uterine fibroids with the VizAblate-System: three- and six-month endpoint results from the FAST-EU study. Gynecol Surg 12:61–70CrossRefPubMedGoogle Scholar
  7. Boruta DM, Shibley T (2016) Power morcellation of unsuspected high – grade leiomyosarcoma within inflated containment bag: 2 – year follow up. J Minim Invasive Gynecol 23:1009–1011CrossRefPubMedGoogle Scholar
  8. Brill AI (2009) Treatment of fibroids via uterine artery occlusion (uterine artery embolization and Doppler-guided uterine artery occlusion) potential role in today’s armamentarium. Arch Gynecol Obstet 280:513–520CrossRefPubMedGoogle Scholar
  9. Brosens I, Johannisson E, Dal Cin P, Deprest J, Van den Berghe H (1996) Analysis of the karyotype and desoxyribonucleic acid content of uterine myomas in premenopausal, menopausal and gonadotropin-releasing hormone agonist treated females. Fertil Steril 66:376–379CrossRefPubMedGoogle Scholar
  10. Buchi K, Keller PJ (1980) Estrogen receptors in normal and myomatous human uteri. Gynecol Obstet Investig 11:59–60Google Scholar
  11. Burbank F, Hutchins FL Jr (2000) Uterine artery occlusion by embolization or surgery for the treatment of fibroids: a unifying hypothesis-transient uterine ischemia. J Am Gynecol Laparosc 7:S1–S49CrossRefGoogle Scholar
  12. Buttram VC, Reiter RC (1981) Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril 36:433–445CrossRefPubMedGoogle Scholar
  13. Cirkel U, Ochs H, Schneider HPG (1992) Experience with leuprorelin acetate depot in the treatment of fibroids: a German multicentre study. Clin Ther 14:37–44PubMedGoogle Scholar
  14. Coddington CC, Collins RL, Shawker TH, Anderson R, Lynn Loriaux D, Winkel CA (1986) Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri. Fertil Steril 45:624–629CrossRefPubMedGoogle Scholar
  15. Creighton S, Bourne TH, Lawton FG et al (1994) Use of transvaginal ultrasonography with color Doppler imaging to determine an appropriate treatment regimen for uterine fibroids with a GnRH agonist before surgery: a preliminary study. Ultrasound Obstet Gynecol 4:494–498CrossRefPubMedGoogle Scholar
  16. Day Baird D, Dunson DB et al (2003) High cumulative incidence of uterine leiomyomata in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107CrossRefGoogle Scholar
  17. Donnez J, Mathieu PE, Bassil S, Smets M, Nisolle M, Berliere M (1996) Laparoscopic myomectomy today. Hum Reprod 11:1837–1840CrossRefPubMedGoogle Scholar
  18. Donnez J, Dolmans MM et al (2016) Uterine fibroid management: from the present to the future. Hum Reprod Update 22:665–685CrossRefPubMedPubMedCentralGoogle Scholar
  19. Doridot V, Dubuisson JB, Chapron C, Fauconnier A et al (2001) Recurrence of leiomyomata after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc 8:495–500CrossRefPubMedGoogle Scholar
  20. Dubuisson JB, Lecuru F, Foulot H et al (1992) Myomectomy by laparoscopy: a preliminary report of 43 cases. Fertil Steril 56:827CrossRefGoogle Scholar
  21. Dubuisson JB, Chapron C, Mouly M et al (1994) Laparoscopic myomectomy. In: Donnez J, Nisolle M (Hrsg) An atlas of laser laparoscopy and hysteroscopy. Parthenon, New York, S 187–193Google Scholar
  22. Farhi J, Askhenazi J, Feldberg D, Dicker D, Orvieto R et al (1995) Effect of uterine leiomyomata on the results of in-vitro-fertilization treatment. Hum Reprod 10:2576–2578CrossRefPubMedGoogle Scholar
  23. Felberbaum RE, Germer U, Ludwig M, Riethmüller-Winzen H, Heise S, Buttge I, Bauer O, Reissmann T, Engel J, Diedrich K (1998) Treatment of uterine fibroids with a slow release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix. Hum Reprod 13:1660–1668CrossRefPubMedGoogle Scholar
  24. Filicori M, Hall DA, Loughlin JS, Rivier J, Vale W, Crowle WF (1983) A conservative approach to the management of uterine leiomyomata: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am J Obstet Gynecol 147:72CrossRefGoogle Scholar
  25. Findlay S (1990) The health-insurance factor. US News World Rep 30:157Google Scholar
  26. Friedman AJ, Barbieri RL, Benacerraf BR, Schiff I (1987) Treatment of leiomyomata with intranasla or subcutanous leuprolide, a gonadotropin-releasing hormone agonist. Fertil Steril 48:560–564CrossRefPubMedGoogle Scholar
  27. Frishman GN, Jurema MW (2005) Myomas and myomectomy. J Minim Invasive Gynecol 12:443–456CrossRefPubMedGoogle Scholar
  28. Funaki K, Fukunishi H, Sawada K (2009) Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas. 24 month follow-up. Ultrasound Obstet Gynecol 34:584–589Google Scholar
  29. Ginsburg ES, Benosn CB, Garfield JM et al (1993) The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril 60:956–962CrossRefPubMedGoogle Scholar
  30. Goldfarb HA (1999) Combining myoma coagulation with endometrial ablation/resection reduces subsequent surgery rates. JSLS 3:253–260PubMedPubMedCentralGoogle Scholar
  31. Hartmann KE, Birnbaum H, Ben-Hamadi R, Wu EQ, Farrell MH, Spalding J, Stang P (2006) Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 108:930–937CrossRefPubMedGoogle Scholar
  32. Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, Mc Donnold N, Inbar Y, Itzchak Y, Rabinovici J, Kim HS, Geschwind JF, Hesley G, Gostout B, Ehrenstein T, Hengst S, Sklair-Levy M, Shushan A, Jolesz F (2004) MRI guidance of focussed ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 183:1713–1719CrossRefPubMedGoogle Scholar
  33. Jacobson GF, Shaber RE, Armstrong MA, Hung YY (2007) Changes in rates of hysterectomy and uterine conserving procedures for treatment of uterine lyomyoma. Am J Obstet Gynecol 196:601.e1–601.e6CrossRefGoogle Scholar
  34. Kawaguchi K, Fujii S, Konishi I, Iwai T, Nanbu Y, Nonogaki H (1991) Immunohistochemical analysis of estrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Arch [Pathol Anat] 419:309–315CrossRefGoogle Scholar
  35. Kundu S, Zachen M et al (2017) Sarcoma risk in uterine surgery in a tertiary university hospital in germany. Int J Gynecol Cancer 27:961–966CrossRefPubMedGoogle Scholar
  36. Lichtinger M, Herbert S, Memmolo A (2005) Temporary, transvaginal occlusion of the uterine arteries: a feasibility and safety study. J Minim Invasive Gynecol 12:40–42CrossRefPubMedGoogle Scholar
  37. Luo X, Ding L, Xu J, Chegini N (2005) Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 146:1097–1118CrossRefPubMedGoogle Scholar
  38. Maresh MJA, Netcalfe MA, McPherson K et al (2002) The VALUE national hysterectomy study: description of the patients and their surgery. BJOG 109:302–312CrossRefPubMedGoogle Scholar
  39. Martin-Chavez EB, Brum IS, Stoll J, Capp E, Corleta HE (2004) Insulin-like-growth-factor I receptor mRNA expression and autophosphorylation in human myometrium and leiomyoma. Gynecol Obstet Investig 57:210–213CrossRefGoogle Scholar
  40. Narayam R, Goswamy RK (1994) Treatment of submucous fibroids and outcome of assisted conception. J Am Assoc Gynecol Laparosc I:307–311CrossRefGoogle Scholar
  41. Nezhat C, Nezhat F, Silfen SL et al (1991) Laparoscopic myomectomy. Int J Fertil 36:275–280PubMedGoogle Scholar
  42. Nisolle M, Smets M, Malvaux V, Anaf V, Donnez J (1993) Laparoscopic myolysis with Nd: YAG laser. J Gynecol Surg 9:95–99CrossRefPubMedGoogle Scholar
  43. Oliver JA Jr, Lance JS (1979) Selective embolization to control massive hemorrhage following pelvic surgery. Am J Obstet Gynecol 135:431–432CrossRefPubMedGoogle Scholar
  44. Pados G, Tsolakidis D et al (2017) Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive – age women. Hum Reprod 32:2036–2041CrossRefPubMedGoogle Scholar
  45. Pandis N, Heim S, Willen H, Bardi G, Flodérus UM, Mandahl N (1991) Histologic-cytogenetic correlations in uterine leiomyomas. Int J Gynecol Cancer 1:163–168CrossRefGoogle Scholar
  46. Park KH, Kim JY, Shin JS et al (2003) Treatment outcomes of uterine embolization and laparoscopic uterine artery ligation for uterine myoma. Yonsei Med J 44:694–702CrossRefPubMedGoogle Scholar
  47. Parker WH (2007) Etiology, symptomatology and diagnosis of uterine myomas. Fertil Steril 87:725–736CrossRefPubMedGoogle Scholar
  48. Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS (1996) Laparoscopic leiomyoma coagulation. J Am Assoc Gynecol Laparosc 3:S39PubMedGoogle Scholar
  49. Pollow K, Geilfuss J, Boquoi E, Pollow B (1978) Estrogen and progesterone binding proteins in normal human myometrium and leiomyoma tissue. J Clin Chem Clin Biochem 16:503–511PubMedGoogle Scholar
  50. Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulletti C, Flamigni C (2000) Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 15:2663–2668CrossRefPubMedGoogle Scholar
  51. Sharp HT (2006) Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata. Obstet Gynecol 108:990–1003CrossRefPubMedGoogle Scholar
  52. Spies JB, Cooper JM et al (2004) Outcome of uterine embolization and hysterectomy for leiomyomas: results of a multicenter study. Am J Obstet Gynecol 191:22–31CrossRefPubMedGoogle Scholar
  53. Stewart EA, Rabinovici J, Tempany CM et al (2006) Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 85:22–29CrossRefPubMedGoogle Scholar
  54. Sunkara SK, Khairy M, El-Toukhy T, Khalaf Y, Coomarasamy A (2010) The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis. Hum Reprod 25:418–429CrossRefPubMedGoogle Scholar
  55. Townsend DE, Sparkes RS, Baluda MC, McClelland G (1970) Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis of glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107:1168–1173CrossRefPubMedGoogle Scholar
  56. Varasteh NN, Neuwirth RS et al (1999) Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women. Obstet Gynecol 94:168–171PubMedGoogle Scholar
  57. Vilos GA, Hollett-Caines J, Burbank F (2006) Uterine artery occlusion: what is the evidence? Clin Obstet Gynecol 49:798–810CrossRefPubMedGoogle Scholar
  58. Volkers NA, Hehenkamp WJ, Birnie E et al (2007) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol 165:519.e1–519.e11CrossRefGoogle Scholar
  59. Wamsteker K, Emanuel MH, de Kruif JH (1993) Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol 82:736–740PubMedGoogle Scholar
  60. Wilson EA, Yang F, Rees ED (1980) Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissue. Obstet Gynecol 55:20–24PubMedGoogle Scholar
  61. Zander J (1986) Milestones in gynecology and obstetrics. In: Ludwig H, Thomsen K (Hrsg) Proceedings of the XIth world congress of gynecology and obstetrics, Berlin, 1985. Springer, Berlin/Heidelberg/New York, S 3–24Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Frauenheilkunde und GeburtshilfeKlinikum Kempten Klinikverbund Kempten – OberallgäuKemptenDeutschland

Personalised recommendations